Krensavage Asset Management, LLC Long-Term Concentrated

Location: NEW YORK, NY

CIK: 0001609251 · Show all filings

Period: Q1 2026 (← Previous)

Filing Date: May 15, 2026

Total Value: $256K (100.0% shares, 0.0% debt)

Holdings (20)

New Positions (5)

INDV INDIVIOR PHARMACEUTICALS INC 4.0%

Value $10,349 Shares 339,532 Est. Cost — Unrealized —

EMBC EMBECTA CORP 2.5%

Value $6,500 Shares 735,340 Est. Cost — Unrealized —

ARDX ARDELYX INC 1.2%

Value $2,995 Shares 500,000 Est. Cost — Unrealized —

INMD INMODE LTD 0.6%

Value $1,654 Shares 120,942 Est. Cost — Unrealized —

ABT ABBOTT LABORATORIES 0.2%

Value $513 Shares 5,000 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
INDV	INDIVIOR PHARMACEUTICALS INC	339,532	$10,349	4.0%	—	—	COM	45579U109
EMBC	EMBECTA CORP	735,340	$6,500	2.5%	—	—	COM	29082K105
ARDX	ARDELYX INC	500,000	$2,995	1.2%	—	—	COM	039697107
INMD	INMODE LTD	120,942	$1,654	0.6%	—	—	COM	M5425M103
ABT	ABBOTT LABORATORIES	5,000	$513	0.2%	—	—	COM	002824100

Increased Positions (4)

ENTA ENANTA PHARMACEUTICALS INC 14.2%

Value $36,199 (-99.9%) Shares 2,866,138 (+3.6%) Est. Cost — Unrealized —

RARE ULTRAGENYX PHARMACEUTICAL IN 3.2%

Value $8,189 (-99.8%) Shares 390,879 (+161.2%) Est. Cost — Unrealized —

BIIB BIOGEN INC 1.4%

Value $3,667 (-99.8%) Shares 20,000 (+100.0%) Est. Cost — Unrealized —

EOLS EVOLUS INC 0.3%

Value $649 (-99.9%) Shares 157,985 (+58.0%) Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ENTA	ENANTA PHARMACEUTICALS INC	2,866,138 (+3.6%)	$36,199 (-99.9%)	14.2%	—	—	COM	29251M106
RARE	ULTRAGENYX PHARMACEUTICAL IN	390,879 (+161.2%)	$8,189 (-99.8%)	3.2%	—	—	COM	90400D108
BIIB	BIOGEN INC	20,000 (+100.0%)	$3,667 (-99.8%)	1.4%	—	—	COM	09062X103
EOLS	EVOLUS INC	157,985 (+58.0%)	$649 (-99.9%)	0.3%	—	—	COM	30052C107

Exited Positions (3)

— AVADEL PHARMACEUTICALS 7213.2%

Value $18.44M Shares 855,860 Est. Cost — Unrealized —

CAH CARDINAL HEALTH INC 5926.9%

Value $15.15M Shares 73,745 Est. Cost — Unrealized —

— INDIVIOR PLC 4764.2%

Value $12.18M Shares 339,532 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	AVADEL PHARMACEUTICALS	855,860	$18.44M	7213.2%	—	—	—	G29687103
CAH	CARDINAL HEALTH INC	73,745	$15.15M	5926.9%	—	—	—	14149Y108
—	INDIVIOR PLC	339,532	$12.18M	4764.2%	—	—	—	G4766E116

Decreased Positions (4)

UTHR UNITED THERAPEUTICS CORP 19.5%

Value $49,978 (-99.9%) Shares 84,282 (-7.7%) Est. Cost — Unrealized —

EXEL EXELIXIS INC 7.0%

Value $17,829 (-99.9%) Shares 415,693 (-15.8%) Est. Cost — Unrealized —

SUPN SUPERNUS PHARMACEUTICALS INC 5.7%

Value $14,508 (-99.9%) Shares 280,681 (-10.5%) Est. Cost — Unrealized —

BNTX BIONTECH SE-ADR 2.1%

Value $5,290 (-99.9%) Shares 59,523 (-40.2%) Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
UTHR	UNITED THERAPEUTICS CORP	84,282 (-7.7%)	$49,978 (-99.9%)	19.5%	—	—	COM	91307C102
EXEL	EXELIXIS INC	415,693 (-15.8%)	$17,829 (-99.9%)	7.0%	—	—	COM	30161Q104
SUPN	SUPERNUS PHARMACEUTICALS INC	280,681 (-10.5%)	$14,508 (-99.9%)	5.7%	—	—	COM	868459108
BNTX	BIONTECH SE-ADR	59,523 (-40.2%)	$5,290 (-99.9%)	2.1%	—	—	ADR	09075V102

Unchanged Positions (7)

BMRN BIOMARIN PHARMACEUTICAL INC 11.6%

Value $29,645 Shares 524,786 Est. Cost — Unrealized —

JAZZ JAZZ PHARMACEUTICALS PLC 12.4%

Value $31,726 Shares 167,816 Est. Cost — Unrealized —

SNY SANOFI-ADR 6.1%

Value $15,608 Shares 323,946 Est. Cost — Unrealized —

VNDA VANDA PHARMACEUTICALS INC 3.2%

Value $8,156 Shares 1,180,388 Est. Cost — Unrealized —

GSK GSK PLC-SPON ADR 2.1%

Value $5,338 Shares 96,729 Est. Cost — Unrealized —

REGN REGENERON PHARMACEUTICALS 1.2%

Value $3,091 Shares 4,000 Est. Cost — Unrealized —

ALKS ALKERMES PLC 1.5%

Value $3,813 Shares 107,822 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
BMRN	BIOMARIN PHARMACEUTICAL INC	524,786	$29,645	11.6%	—	—	COM	09061G101
JAZZ	JAZZ PHARMACEUTICALS PLC	167,816	$31,726	12.4%	—	—	COM	G50871105
SNY	SANOFI-ADR	323,946	$15,608	6.1%	—	—	ADR	80105N105
VNDA	VANDA PHARMACEUTICALS INC	1,180,388	$8,156	3.2%	—	—	COM	921659108
GSK	GSK PLC-SPON ADR	96,729	$5,338	2.1%	—	—	ADR	37733W204
REGN	REGENERON PHARMACEUTICALS	4,000	$3,091	1.2%	—	—	COM	75886F107
ALKS	ALKERMES PLC	107,822	$3,813	1.5%	—	—	COM	G01767105